NASH
Clinical trials for NASH explained in plain language.
Never miss a new study
Get alerted when new NASH trials appear
Sign up with your email to follow new studies for NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop liver failure in NASH patients
Disease control OngoingThis phase 3 study tests whether a daily pill called resmetirom can prevent serious liver events like liver failure, need for transplant, or bleeding in people with NASH cirrhosis. About 845 adults with well-compensated cirrhosis will receive either the drug or a placebo. The goa…
Matched conditions: NASH
Phase: PHASE3 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New RNA drug aims to reverse liver damage in NASH patients
Disease control OngoingThis phase 2 trial is testing an experimental drug called VSA006 in 48 Chinese adults with NASH, a type of fatty liver disease that can lead to cirrhosis. VSA006 is an RNA-based drug designed to lower a liver protein linked to disease progression. The study compares VSA006 inject…
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New scanner aims to spot fatty liver without needles
Diagnosis TerminatedThis study was designed to test a new thermo-acoustic imaging device that may help diagnose fatty liver disease without invasive procedures. It would have compared the device's accuracy to standard MRI scans in adults aged 18-70 with known or suspected fatty liver. However, the s…
Matched conditions: NASH
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Can MRI and ultrasound spot fatty liver in kids without a needle?
Knowledge-focused OngoingThis study tests whether MRI and ultrasound can accurately measure liver fat in children aged 10-14, both those with obesity and those at a healthy weight. Researchers will check if the scans are reliable and easy to perform. The goal is to develop a non-invasive tool to diagnose…
Matched conditions: NASH
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC